Derek J. Maetzold's most recent trade in Castle Biosciences Inc was a trade of 1,339 Common Stock done at an average price of $20.0 . Disclosure was reported to the exchange on Aug. 15, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.04 per share. | 15 Aug 2025 | 1,339 | 68,344 (0%) | 0% | 20.0 | 26,834 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 19.50 per share. | 13 Aug 2025 | 43,019 | 69,683 (0%) | 0% | 19.5 | 839,043 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2025 | 66,991 | 136,674 (0%) | 0% | 0 | Common Stock | |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2025 | 66,991 | 0 | - | - | Performance-Based Stock Unit | |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.36 per share. | 08 Aug 2025 | 23,972 | 112,702 (0%) | 0% | 19.4 | 464,098 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.30 per share. | 27 Jun 2025 | 8,068 | 52,923 (0%) | 0% | 20.3 | 163,780 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.30 per share. | 27 Jun 2025 | 6,924 | 44,986 (0%) | 0% | 20.3 | 140,557 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.30 per share. | 27 Jun 2025 | 4,944 | 69,683 (0%) | 0% | 20.3 | 100,363 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.30 per share. | 27 Jun 2025 | 660 | 3,615 (0%) | 0% | 20.3 | 13,398 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.30 per share. | 27 Jun 2025 | 660 | 3,615 (0%) | 0% | 20.3 | 13,398 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.30 per share. | 27 Jun 2025 | 660 | 3,615 (0%) | 0% | 20.3 | 13,398 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.30 per share. | 27 Jun 2025 | 660 | 3,618 (0%) | 0% | 20.3 | 13,398 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 21.52 per share. | 21 Apr 2025 | 2,017 | 60,991 (0%) | 0% | 21.5 | 43,402 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 21.52 per share. | 21 Apr 2025 | 1,731 | 51,910 (0%) | 0% | 21.5 | 37,248 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 21.52 per share. | 21 Apr 2025 | 1,236 | 74,627 (0%) | 0% | 21.5 | 26,596 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 21.52 per share. | 21 Apr 2025 | 165 | 4,275 (0%) | 0% | 21.5 | 3,550 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 21.52 per share. | 21 Apr 2025 | 165 | 4,275 (0%) | 0% | 21.5 | 3,550 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 21.52 per share. | 21 Apr 2025 | 165 | 4,275 (0%) | 0% | 21.5 | 3,550 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 21.52 per share. | 21 Apr 2025 | 165 | 4,278 (0%) | 0% | 21.5 | 3,550 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.22 per share. | 08 Apr 2025 | 1,669 | 63,008 (0%) | 0% | 20.2 | 33,746 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.22 per share. | 08 Apr 2025 | 1,432 | 53,641 (0%) | 0% | 20.2 | 28,954 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.22 per share. | 08 Apr 2025 | 1,023 | 75,863 (0%) | 0% | 20.2 | 20,684 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.03 per share. | 08 Apr 2025 | 348 | 64,677 (0%) | 0% | 20.0 | 6,970 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.03 per share. | 08 Apr 2025 | 299 | 55,073 (0%) | 0% | 20.0 | 5,989 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.03 per share. | 08 Apr 2025 | 213 | 76,886 (0%) | 0% | 20.0 | 4,266 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.22 per share. | 08 Apr 2025 | 137 | 4,440 (0%) | 0% | 20.2 | 2,770 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.22 per share. | 08 Apr 2025 | 137 | 4,440 (0%) | 0% | 20.2 | 2,770 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.22 per share. | 08 Apr 2025 | 137 | 4,440 (0%) | 0% | 20.2 | 2,770 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.22 per share. | 08 Apr 2025 | 135 | 4,443 (0%) | 0% | 20.2 | 2,730 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.03 per share. | 08 Apr 2025 | 30 | 4,578 (0%) | 0% | 20.0 | 601 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.04 per share. | 08 Apr 2025 | 28 | 4,577 (0%) | 0% | 20.0 | 561 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.04 per share. | 08 Apr 2025 | 28 | 4,577 (0%) | 0% | 20.0 | 561 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.04 per share. | 08 Apr 2025 | 28 | 4,577 (0%) | 0% | 20.0 | 561 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.30 per share. | 26 Mar 2025 | 2,017 | 65,025 (0%) | 0% | 20.3 | 40,945 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.30 per share. | 26 Mar 2025 | 1,731 | 55,372 (0%) | 0% | 20.3 | 35,139 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.30 per share. | 26 Mar 2025 | 1,236 | 77,099 (0%) | 0% | 20.3 | 25,091 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.30 per share. | 26 Mar 2025 | 165 | 4,605 (0%) | 0% | 20.3 | 3,350 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.30 per share. | 26 Mar 2025 | 165 | 4,605 (0%) | 0% | 20.3 | 3,350 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.30 per share. | 26 Mar 2025 | 165 | 4,605 (0%) | 0% | 20.3 | 3,350 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.30 per share. | 26 Mar 2025 | 165 | 4,608 (0%) | 0% | 20.3 | 3,350 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.05 per share. | 07 Mar 2025 | 20,516 | 82,588 (0%) | 0% | 20.1 | 411,387 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 19.52 per share. | 07 Mar 2025 | 2,130 | 78,335 (0%) | 0% | 19.5 | 41,573 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.74 per share. | 07 Mar 2025 | 2,123 | 80,465 (0%) | 0% | 20.7 | 44,040 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.05 per share. | 07 Mar 2025 | 1,828 | 67,231 (0%) | 0% | 20.1 | 36,655 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.05 per share. | 07 Mar 2025 | 1,569 | 57,265 (0%) | 0% | 20.1 | 31,462 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.75 per share. | 07 Mar 2025 | 189 | 67,042 (0%) | 0% | 20.7 | 3,921 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.75 per share. | 07 Mar 2025 | 162 | 57,103 (0%) | 0% | 20.7 | 3,361 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.05 per share. | 07 Mar 2025 | 150 | 4,785 (0%) | 0% | 20.1 | 3,008 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.05 per share. | 07 Mar 2025 | 150 | 4,785 (0%) | 0% | 20.1 | 3,008 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.05 per share. | 07 Mar 2025 | 150 | 4,785 (0%) | 0% | 20.1 | 3,008 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.05 per share. | 07 Mar 2025 | 150 | 4,788 (0%) | 0% | 20.1 | 3,008 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.73 per share. | 07 Mar 2025 | 15 | 4,773 (0%) | 0% | 20.7 | 311 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.73 per share. | 07 Mar 2025 | 15 | 4,770 (0%) | 0% | 20.7 | 311 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.73 per share. | 07 Mar 2025 | 15 | 4,770 (0%) | 0% | 20.7 | 311 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.73 per share. | 07 Mar 2025 | 15 | 4,770 (0%) | 0% | 20.7 | 311 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 111,948 | 111,948 | - | - | Restricted Stock Units | |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 31,109 | 111,927 (0%) | 0% | - | Common Stock | |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 31,109 | 93,328 | - | - | Restricted Stock Units | |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.23 per share. | 04 Mar 2025 | 7,576 | 104,351 (0%) | 0% | 22.2 | 168,414 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.86 per share. | 04 Mar 2025 | 2,022 | 69,059 (0%) | 0% | 20.9 | 42,175 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.86 per share. | 04 Mar 2025 | 1,739 | 58,834 (0%) | 0% | 20.9 | 36,272 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.86 per share. | 04 Mar 2025 | 1,247 | 103,104 (0%) | 0% | 20.9 | 26,010 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.86 per share. | 04 Mar 2025 | 172 | 4,938 (0%) | 0% | 20.9 | 3,588 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.86 per share. | 04 Mar 2025 | 169 | 4,935 (0%) | 0% | 20.9 | 3,525 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.86 per share. | 04 Mar 2025 | 169 | 4,935 (0%) | 0% | 20.9 | 3,525 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.86 per share. | 04 Mar 2025 | 169 | 4,935 (0%) | 0% | 20.9 | 3,525 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 27.51 per share. | 13 Jan 2025 | 556 | 81,248 (0%) | 0% | 27.5 | 15,296 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 28.65 per share. | 13 Jan 2025 | 399 | 80,849 (0%) | 0% | 28.6 | 11,431 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 27.51 per share. | 13 Jan 2025 | 285 | 71,301 (0%) | 0% | 27.5 | 7,840 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 27.51 per share. | 13 Jan 2025 | 267 | 60,780 (0%) | 0% | 27.5 | 7,345 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 28.65 per share. | 13 Jan 2025 | 204 | 71,097 (0%) | 0% | 28.7 | 5,845 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 28.65 per share. | 13 Jan 2025 | 192 | 60,588 (0%) | 0% | 28.7 | 5,501 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 27.51 per share. | 13 Jan 2025 | 85 | 5,169 (0%) | 0% | 27.5 | 2,338 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 27.51 per share. | 13 Jan 2025 | 85 | 5,169 (0%) | 0% | 27.5 | 2,338 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 27.51 per share. | 13 Jan 2025 | 85 | 5,169 (0%) | 0% | 27.5 | 2,338 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 27.51 per share. | 13 Jan 2025 | 85 | 5,175 (0%) | 0% | 27.5 | 2,338 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 28.66 per share. | 13 Jan 2025 | 61 | 5,108 (0%) | 0% | 28.7 | 1,748 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 28.66 per share. | 13 Jan 2025 | 61 | 5,108 (0%) | 0% | 28.7 | 1,748 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 28.65 per share. | 13 Jan 2025 | 60 | 5,109 (0%) | 0% | 28.7 | 1,719 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 28.65 per share. | 13 Jan 2025 | 60 | 5,115 (0%) | 0% | 28.7 | 1,719 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 29.48 per share. | 13 Jan 2025 | 31 | 80,818 (0%) | 0% | 29.5 | 914 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 29.50 per share. | 13 Jan 2025 | 16 | 71,081 (0%) | 0% | 29.5 | 472 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 29.47 per share. | 13 Jan 2025 | 15 | 60,573 (0%) | 0% | 29.5 | 442 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 29.40 per share. | 13 Jan 2025 | 5 | 5,104 (0%) | 0% | 29.4 | 147 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 29.40 per share. | 13 Jan 2025 | 5 | 5,110 (0%) | 0% | 29.4 | 147 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 29.50 per share. | 13 Jan 2025 | 4 | 5,104 (0%) | 0% | 29.5 | 118 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 29.50 per share. | 13 Jan 2025 | 4 | 5,104 (0%) | 0% | 29.5 | 118 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 30.17 per share. | 06 Jan 2025 | 1,727 | 82,047 (0%) | 0% | 30.2 | 52,112 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 30.18 per share. | 06 Jan 2025 | 885 | 71,710 (0%) | 0% | 30.2 | 26,705 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 30.17 per share. | 06 Jan 2025 | 831 | 61,164 (0%) | 0% | 30.2 | 25,075 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 28.42 per share. | 06 Jan 2025 | 678 | 84,084 (0%) | 0% | 28.4 | 19,269 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 28.42 per share. | 06 Jan 2025 | 346 | 72,755 (0%) | 0% | 28.4 | 9,834 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 28.42 per share. | 06 Jan 2025 | 325 | 62,144 (0%) | 0% | 28.4 | 9,237 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 29.13 per share. | 06 Jan 2025 | 310 | 83,774 (0%) | 0% | 29.1 | 9,031 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 30.17 per share. | 06 Jan 2025 | 264 | 5,296 (0%) | 0% | 30.2 | 7,966 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 30.18 per share. | 06 Jan 2025 | 262 | 5,291 (0%) | 0% | 30.2 | 7,906 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 30.18 per share. | 06 Jan 2025 | 262 | 5,291 (0%) | 0% | 30.2 | 7,906 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 30.18 per share. | 06 Jan 2025 | 262 | 5,291 (0%) | 0% | 30.2 | 7,906 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 30.14 per share. | 06 Jan 2025 | 243 | 81,804 (0%) | 0% | 30.1 | 7,324 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 29.13 per share. | 06 Jan 2025 | 160 | 72,595 (0%) | 0% | 29.1 | 4,661 | Common Stock |
Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 29.13 per share. | 06 Jan 2025 | 149 | 61,995 (0%) | 0% | 29.1 | 4,341 | Common Stock |